For example, doxorubicin, which is active against most SyS cell lines in vitro, but demonstrates only subtle cytoreduction in a minority of human synovial sarcoma patients, had similar response rates in the SyS conditional mouse model [41]. The gene discussed is SARS2; the disease is synovial sarcoma.